1. Clinical assessment of gepotidacin (GSK2140944) as a victim and perpetrator of drug–drug interactions via CYP3A metabolism and transporters. Issue 4 (23rd January 2023) Authors: Barth, Aline; Perry, Caroline R.; Shabbir, Shaila; Zamek‐Gliszczynski, Maciej J.; Thomas, Sebin; Dumont, Etienne F.; Brimhall, Darin B.; Nguyen, Dung; Srinivasan, Meenakshi; Swift, Brandon Journal: Clinical and translational science Issue: Volume 16:Issue 4(2023) Page Start: 647 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacokinetic, Safety, and Tolerability Evaluations of Gepotidacin (GSK2140944) in Healthy Japanese Participants. Issue 1 (5th December 2022) Authors: Barth, Aline; Hossain, Mohammad; Perry, Caroline R.; Gross, Annette S.; Ogura, Hirofumi; Shabbir, Shaila; Thomas, Sebin; Dumont, Etienne F.; Brimhall, Darin B.; Srinivasan, Meenakshi; Swift, Brandon Journal: Clinical pharmacology in drug development Issue: Volume 12:Issue 1(2023) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗